UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027512
Receipt number R000031534
Scientific Title The prospective research of the effect of topical ripasudil for pterigyum
Date of disclosure of the study information 2017/05/29
Last modified on 2019/02/20 11:40:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The prospective research of the effect of topical ripasudil for pterigyum

Acronym

The effect of topical ripasudil for pterygium

Scientific Title

The prospective research of the effect of topical ripasudil for pterigyum

Scientific Title:Acronym

The effect of topical ripasudil for pterygium

Region

Japan


Condition

Condition

Pterygium

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of topical ripasudil for pterygium prospectively.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We capture the image of anterior segment of eyes and evaluate the time-dependent change of the area of pterygium.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

0.4% ripasudil is instilled for treatment group twice a day (morning and evening). Instillation is continued for six months.

Interventions/Control_2

No treatment.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Pterygium does not regress spontaneously during observation period for two months.
2) The edge of pterygium is smaller than two thirds of corneal radius.
3) A person is more than 20 years old.
4) The consent of the document is obtained.

Key exclusion criteria

1) Persons who are contraindicated for the test drugs.
2) Persons who are allergic to ripasudil.
3) Persons who had severe corneal, conjunctival and intraocular disease.
4) Persons who are thought as inappropriate by principal or subprincipal doctors.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Miyata Kazunori

Organization

Miyata Eye Hospital

Division name

Ophthalmology

Zip code


Address

6-3 Kurahara, Miyakonojyo, Miyazaki, 885-0051, Japan

TEL

0986-22-1441

Email

miyata@miyata-med.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ono Takashi

Organization

Miyata Eye Hospital

Division name

Ophthalmology

Zip code


Address

6-3 Kurahara, Miyakonojyo, Miyazaki, 885-0051, Japan

TEL

0986-22-1441

Homepage URL


Email

ono@miyata-med.ne.jp


Sponsor or person

Institute

Miyata Eye Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 10 Month 12 Day

Date of IRB


Anticipated trial start date

2017 Year 01 Month 05 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 05 Month 28 Day

Last modified on

2019 Year 02 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031534


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name